USCAP Lower Female Genital Tract Pathology: Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025

Overview

USCAP Lower Female Genital Tract Pathology: Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025 is a comprehensive review course focusing on the classification and reporting of lower female genital tract pathology involving the cervix, vagina, and vulva. This course emphasizes the updates introduced in the 5th edition of the World Health Organization classification system and the new FIGO staging criteria for cervical and vulvar cancers. It includes interactive microscopy cases covering biopsy, resection, and cytopathological specimens, providing a practical approach to morphological assessment alongside strategies for selecting and interpreting immunohistochemical and molecular diagnostic tests.

On-demand pathology education — accessible anytime, anywhere.

Agenda

This course offers detailed presentations and supporting documents that cover key aspects of lower female genital tract pathology. The agenda includes:

• Cervical Glandular Pathology — Joseph T. Rabban, MD, MPH (2 Presentations, 2 Documents)
• Cervical Squamous Pathology and HPV Screening — Christina S. Kong, MD (2 Presentations, 2 Documents)
• Vulvar Squamous Cell Carcinoma and Precursors — Stephanie Lynn Skala, MD (2 Presentations, 2 Documents)
• Non-Neoplastic Vulvar Pathology — Yuna Kang, MD (2 Presentations, 2 Documents)
• Cervical and Vulvar Mesenchymal Pathology — Oluwole Fadare, MD (2 Presentations, 2 Documents)
• Cervical and Pelvic Cytopathology — Paul N. Staats, MD (1 Presentation, 1 Document)
• FREE SECTION: Lower Anogenital Squamous Terminology (LAST) Guideline Update (1 Presentation, 1 Document)

Learning Objectives

• Apply the current W.H.O. criteria for morphological, immunohistochemical, and molecular diagnostic classification of cervical and vulvar epithelial tumors, mesenchymal tumors, and their non-neoplastic mimics.
• Assign the current FIGO staging criteria for cervical and vulvar carcinomas, including the alternative Silva pattern of invasiveness for cervical adenocarcinoma.
• Classify non-neoplastic inflammatory and melanocytic disorders of the vulva.
• Diagnose exfoliative cytologic specimens of the cervix using current Bethesda system guidelines as well as pelvic fluid cytology specimens.

Speakers

• Joseph T. Rabban, MD, MPH
• Christina S. Kong, MD
• Stephanie Lynn Skala, MD
• Yuna Kang, MD
• Oluwole Fadare, MD
• Paul N. Staats, MD

Target Audience

This course is designed for practicing pathologists, pathology trainees, and other healthcare professionals involved in the diagnosis and classification of lower female genital tract pathology. It supports those seeking to update their knowledge on the latest WHO classification criteria and FIGO staging systems relevant to gynecologic pathology.

Why This Topic Matters

USCAP Lower Female Genital Tract Pathology: Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025 addresses crucial updates in gynecologic pathology that impact diagnostic accuracy and reporting consistency. Mastery of these classification and staging systems is essential for pathologists interpreting lower female genital tract specimens.

This course, provided through MedHub Central, supports pathology professionals in strengthening their expertise and confidence in applying the newest WHO and FIGO guidelines. Its focus on practical morphology, immunohistochemistry, and molecular diagnostics aligns with ongoing advances in female genital tract pathology.